Intrinsic Value of S&P & Nasdaq Contact Us

Virpax Pharmaceuticals, Inc. VRPX OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
33/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.00
+599900%

Virpax Pharmaceuticals, Inc. (VRPX) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is neutral — 1 Hold.

The consensus price target is $3.00, representing an upside of 599900% from the current price $0.00.

VRPX Stock — 12-Month Price Forecast

$3.00
▲ +599,900.00% Upside
Average Price Target
Based on 1 Wall Street analysts offering 12-month price targets for Virpax Pharmaceuticals, Inc., the price target is $3.00.
The average price target represents a +599,900.00% change from the last price of $0.00.

VRPX Analyst Ratings

Hold
1
Ratings
1 Hold
Based on 1 analysts giving stock ratings to Virpax Pharmaceuticals, Inc. in the past 3 months
Rating breakdown
Hold
1 100%
0%
Buy
0 analysts
100%
Hold
1 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message